143 related articles for article (PubMed ID: 38794808)
1. Insight into the role of IRF7 in skin and connective tissue diseases.
Wang L; Yang F; Ye J; Zhang L; Jiang X
Exp Dermatol; 2024 May; 33(5):e15083. PubMed ID: 38794808
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
3. A BET inhibitor, NHWD-870, can downregulate dendritic cells maturation via the IRF7-mediated signaling pathway to ameliorate imiquimod-induced psoriasis-like murine skin inflammation.
Jin L; Dong L; Pei S; Chen X; Kuang Y; Chen W; Zhu W; Yin M
Eur J Pharmacol; 2024 Apr; 968():176382. PubMed ID: 38311277
[TBL] [Abstract][Full Text] [Related]
4. IRF7: activation, regulation, modification and function.
Ning S; Pagano JS; Barber GN
Genes Immun; 2011 Sep; 12(6):399-414. PubMed ID: 21490621
[TBL] [Abstract][Full Text] [Related]
5. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
6. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.
Carmona FD; Gutala R; Simeón CP; Carreira P; Ortego-Centeno N; Vicente-Rabaneda E; García-Hernández FJ; García de la Peña P; Fernández-Castro M; Martínez-Estupiñán L; Egurbide MV; Tsao BP; Gourh P; Agarwal SK; Assassi S; Mayes MD; Arnett FC; Tan FK; Martín J;
Ann Rheum Dis; 2012 Jan; 71(1):114-9. PubMed ID: 21926187
[TBL] [Abstract][Full Text] [Related]
7. Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.
Zhang LJ
Front Immunol; 2019; 10():1440. PubMed ID: 31293591
[TBL] [Abstract][Full Text] [Related]
8. Chicken interferon regulatory factor 7 (IRF7) can control ALV-J virus infection by triggering type I interferon production through affecting genes related with innate immune signaling pathway.
Wang Y; Yang F; Yin H; He Q; Lu Y; Zhu Q; Lan X; Zhao X; Li D; Liu Y; Xu H
Dev Comp Immunol; 2021 Jun; 119():104026. PubMed ID: 33497733
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Interferon Regulatory Factor 7 in Nicotine's Suppression of Antiviral Immune Responses.
Han H; Huang W; Du W; Shen Q; Yang Z; Li MD; Chang SL
J Neuroimmune Pharmacol; 2019 Dec; 14(4):551-564. PubMed ID: 31154625
[TBL] [Abstract][Full Text] [Related]
10. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.
Unterholzner L; Sumner RP; Baran M; Ren H; Mansur DS; Bourke NM; Randow F; Smith GL; Bowie AG
PLoS Pathog; 2011 Sep; 7(9):e1002247. PubMed ID: 21931555
[TBL] [Abstract][Full Text] [Related]
11. Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.
Bujor AM; El Adili F; Parvez A; Marden G; Trojanowska M
Front Immunol; 2020; 11():800. PubMed ID: 32508810
[TBL] [Abstract][Full Text] [Related]
12. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
Sun L; Liu W; Zhang LJ
J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
[TBL] [Abstract][Full Text] [Related]
13. Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis.
Chujo S; Shirasaki F; Kondo-Miyazaki M; Ikawa Y; Takehara K
J Cell Physiol; 2009 Jul; 220(1):189-95. PubMed ID: 19277979
[TBL] [Abstract][Full Text] [Related]
14. Novel insights on the role of the innate immune system in systemic sclerosis.
York MR
Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
[TBL] [Abstract][Full Text] [Related]
15. IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis.
Rezaei R; Mahmoudi M; Gharibdoost F; Kavosi H; Dashti N; Imeni V; Jamshidi A; Aslani S; Mostafaei S; Vodjgani M
Int J Rheum Dis; 2017 Oct; 20(10):1551-1561. PubMed ID: 28952189
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.
Agarwal SK; Wu M; Livingston CK; Parks DH; Mayes MD; Arnett FC; Tan FK
Arthritis Res Ther; 2011 Jan; 13(1):R3. PubMed ID: 21223583
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.
Joo CH; Shin YC; Gack M; Wu L; Levy D; Jung JU
J Virol; 2007 Aug; 81(15):8282-92. PubMed ID: 17522209
[TBL] [Abstract][Full Text] [Related]
18. Innate Immune Response of Primary Human Keratinocytes to West Nile Virus Infection and Its Modulation by Mosquito Saliva.
Garcia M; Alout H; Diop F; Damour A; Bengue M; Weill M; Missé D; Lévêque N; Bodet C
Front Cell Infect Microbiol; 2018; 8():387. PubMed ID: 30450338
[TBL] [Abstract][Full Text] [Related]
19. The role of toll-like receptors in host defenses and their relevance to dermatologic diseases.
Terhorst D; Kalali BN; Ollert M; Ring J; Mempel M
Am J Clin Dermatol; 2010; 11(1):1-10. PubMed ID: 20000870
[TBL] [Abstract][Full Text] [Related]
20. Pattern recognition receptors in immune disorders affecting the skin.
de Koning HD; Simon A; Zeeuwen PL; Schalkwijk J
J Innate Immun; 2012; 4(3):225-40. PubMed ID: 22398307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
